The present invention is directed to methods of inhibiting a tauopathy in a patient by administration of a compound of formula I:
Novel aminothienopyridazine compounds are also described.
本发明涉及通过给予I型化合物来抑制患者的tau病变的方法:还描述了新的氨基噻吩吡嗪化合物。
El-Kousy, Salah; El-Sakka, Ibraheim; El-Torgoman, Abdel Monem, Collection of Czechoslovak Chemical Communications, 1990, vol. 55, # 12, p. 2977 - 2986